Dapsone in Hidradenitis Suppurativa: A Systematic Review.

Rabindranathnambi, Aswatha; Jeevankumar, Balasubramanian

Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent disease, usually presenting after puberty with inflammatory lesions that mainly affect the apocrine gland-bearing areas of the body, most commonly the axillary, inguinal and anogenital regions. The treatment of HS is associated with certain challenges due to intrinsic resistance to various treatments and the presence of comorbidities and complications. The antibiotic dapsone is an established treatment for HS, but the current evidence base is limited. The aim of this review is to systematically review the literature on the efficacy of dapsone in the treatment of HS. Methods: The Cochrane, PubMed and CINAHL databases were searched for relevant articles to be included in the systematic review. Results: A total of seven studies, with a cumulative patient population of 135 patients, were included. Of these 135 patients, 62.2% demonstrated various degrees of improvement following treatment. However, as only three of the seven studies used dapsone monotherapy it is difficult to assess the effectiveness of dapsone because the benefits observed may be due to concurrently administered treatment. Conclusion: Overall, the quality of evidence supporting the use of dapsone is weak. However, it is a well established treatment recommended in current, various national guidelines. There is a crucial need for well-designed randomized controlled trials to support its usage.

HIDRADENITIS suppurativa; DAPSONE; CINAHL database; GROIN; RANDOMIZED controlled trials; INGUINAL hernia

Dermatology & Therapy, 2022, Vol 12, Issue 2, p285

2193-8210

Academic Journal

10.1007/s13555-021-00674-x